
Friday, February 16, 2024 2:30:48 PM
So where does that leave HR - to put it bluntly "they are up shit-creek without a paddle" because after have shorted more than +1 million shares at prices over 4 (and the +300K shares sold immediately after release of report) they have not been able to buy them back at expected sub 2 levels. I know danish retail investors have added close to 400,000 this week .
Hindenburg et al (they were not in this alone) - can (as they did last time) reach out to Wall Street parasites such as H.C. Wainwright and ask them to offer funding to Renovaro. Only this time I am hopefull/certain that Renovaro will find other means of raising capital - other than through the H.C.W-scumbags and the likes. (Wainwright is under investigation for facilitating naked shorting)

Recent RENB News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 07/10/2025 10:45:38 PM
- Smart Healthcare Is Taking Over. Here's Where the Money's Headed • PR Newswire (US) • 06/10/2025 03:17:00 PM
- Smart Healthcare Is Taking Over. Here's Where the Money's Headed • PR Newswire (US) • 06/10/2025 03:13:00 PM
- Smart Healthcare Is Taking Over. Here's Where the Money's Headed • PR Newswire (Canada) • 06/10/2025 03:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2025 08:02:04 PM
- Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform • GlobeNewswire Inc. • 06/03/2025 01:15:00 PM
- AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge • PR Newswire (US) • 05/23/2025 01:19:00 PM
- AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge • PR Newswire (Canada) • 05/23/2025 01:17:00 PM
- AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge • PR Newswire (US) • 05/23/2025 01:17:00 PM
- UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology • GlobeNewswire Inc. • 05/22/2025 07:12:39 PM
- Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology • GlobeNewswire Inc. • 05/22/2025 03:05:00 PM
- Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform • GlobeNewswire Inc. • 05/14/2025 01:15:00 PM
- Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics • GlobeNewswire Inc. • 05/13/2025 01:15:00 PM
- Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs • GlobeNewswire Inc. • 04/22/2025 01:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/18/2025 09:00:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2025 08:55:50 PM
- Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine • GlobeNewswire Inc. • 04/09/2025 01:25:00 PM
- Renovaro Provides Update to Definitive Agreement with Predictive Oncology • GlobeNewswire Inc. • 04/04/2025 01:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2025 12:12:50 PM
- Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology • GlobeNewswire Inc. • 03/03/2025 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2025 09:05:41 PM
- Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine • GlobeNewswire Inc. • 02/26/2025 06:25:00 PM
- Renovaro Announces $15 million in Equity Committed • GlobeNewswire Inc. • 02/26/2025 02:15:00 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM